Xiuning Le, Deputy Section Chief of Thoracic Medical Oncology at MD Anderson Cancer Center, shared a post by International Lung Cancer Summit on X:
“Ready to battle: MARIPOSA vs. FLAURA2 in 1L EGFR lung cancer I will debate, facing off against the brilliant Dr. Tom Newsom-Davis of Westminster at ILCS26 with Alfredo Addeo, Solange Peters.
Your British accent may charm the audience, my friend, but data wins the debate.”
Quoting International Lung Cancer Summit’s post:
“At the ILCS on 26ᵗʰ September, world-class experts Xiuning Le and Tom Newsom-Davis will debate evolving standards in EGFR+ metastatic NSCLC. Dr. Le will spotlight the impact of amivantamab + lazertinib, offering a forward-looking view on how this combo is reshaping patient care.”
More posts featuing Xiuning Le on Tom Newsom-Davis OncoDaily.